-
Meet This BioPharma Company With Several Exciting Drugs In Advanced Clinical Trials
Wednesday, November 9, 2022 - 9:37am | 166Read More...Sign up for this week’s All Access giveaway here! Pnina Fishman, Ph.D., CEO of Can-Fite BioPharma (NYSE: CANF), was a guest on Benzinga’s All Access on Nov 4, 2022. Can-Fite is an Israeli biopharmaceutical company with fully integrated pharmaceutical discovery and clinical...
-
CEO Of Univo Pharmaceuticals Appointed Board Member At Can-Fite
Monday, December 30, 2019 - 10:17am | 215Read More...Can-Fite BioPharma Ltd (NYSE: CANF), an Israeli biotechnology company with a pipeline of proprietary compounds in Phase 2 and 3 clinical development stage that address autoimmune-inflammatory and cancer diseases, last week disclosed that CEO of Univo Pharmaceuticals, Golan Bitton, was elected...
-
Market Wrap For December 30: Markets Quiet Ahead of New Year's Eve
Monday, December 30, 2013 - 5:41pm | 1239Read More...As to be expected for this time of the year, volume was light today with little market moving data or news released. Major indices were virtually flat as Tuesday will mark the final trading session of 2013. Markets will close tomorrow at 4:00 pm EST and remain closed until Thursday morning....
